市場調査レポート
商品コード
1541054
ライブセルイメージング市場レポート:製品、用途、技術、地域別、2024~2032年Live Cell Imaging Market Report by Product, Application, Technology (Time-Lapse Microscopy, Fluorescence Recovery after Photobleaching, Fluorescence Resonance Energy Transfer, High Content Screening, and Others), and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ライブセルイメージング市場レポート:製品、用途、技術、地域別、2024~2032年 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 150 Pages
納期: 2~3営業日
|
世界のライブセルイメージング市場規模は2023年に23億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに46億米ドルに達し、2024~2032年の間に7.7%の成長率(CAGR)を示すと予測しています。タンパク質の研究効率の高さによる需要の高まり、新薬開発のための医療研究における技術革新の進展、座りがちなライフスタイルの定着による様々な慢性疾患の蔓延などが、市場を牽引する主要要因のひとつです。
ライブセルイメージングとは、時間とともに変化する増殖培地中の動的な生きた細胞を調べることです。顕微鏡ステージ上で細胞を培養するための詳細なプロトコールと技術で構成され、リアルタイムで細胞プロセスを追跡するために一定の焦点面を維持します。位相差顕微鏡と明視野に頼って細胞培養を照らし、プラスチド、ミトコンドリア、中心体、小胞体、リボソームなどの様々な細胞小器官を調べる。ライブセルイメージングは、イメージングモダリティ、培地、温度、湿度、pH、浸透圧、光子量に影響されるが、これらは細胞の健康維持に不可欠です。ライブセルイメージングはまた、細胞融合イベントのモニタリング、光脱失後の蛍光回復(FRAP)を用いた分子の移動度の決定、一定期間における凝縮体の成長や老化などの様々な修飾の測定も可能にします。エンドポイントアッセイでは見逃されがちな過渡的事象を可視化し、最適な時間ポイントを明らかにすることで、本質的な細胞データを記載しています。受精プロセス、細胞発生、細胞シグナル伝達プロセス、細胞分化を調べるためによく利用されます。さらに、ライブセルイメージングは細胞培養に関する正確な情報を提供するため、世界中の生物学者、薬理学者、毒物学者に活用されています。
現在、タンパク質や様々な分子間相互作用の研究において、ライブセルイメージングの操作効率による需要の高まりは、市場にプラスの影響を与える主要要因の1つです。これに加えて、個人の様々な生命を脅かす状態を治療するための新薬や治療法を開発するための医療研究における技術革新の数が増加しています。これは、座りっぱなしのライフスタイルの採用による様々な慢性疾患の有病率の増加と相まって、有利な市場展望を提供しています。さらに、医薬品開発プロセスの時間効率とコスト効率を高め、毒性を低減するためにハイコンテントスクリーニング(HCS)の利用が増加していることも、市場の成長を後押ししています。これとは別に、医療インフラを改善し、患者に効果的な治療を提供するための高度な外科手術を開発するために、各国の行政機関が行う投資件数が増加していることも、市場の成長に寄与しています。さらに、細胞の生存率を維持するために研究所でのライブセルイメージングの採用が増加していることも、市場の成長を後押ししています。さらに、新興国市場の主要企業は、カメラ技術、感度、ピクセル密度など、さまざまな機能を強化したライブセルイメージング技術を開発しています。
The global live cell imaging market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032. The escalating demand due to its operational efficiency in studying proteins, rising innovations made in medical research to develop novel drugs, and the growing prevalence of various chronic diseases due to the adoption of sedentary lifestyles represent some of the key factors driving the market.
Live cell imaging refers to the examination of dynamic living cells in their growth medium that change over time. It comprises detailed protocols and techniques to culture cells on the microscope stage and maintains a constant focal plane to follow cellular processes in real time. It relies on phase contrast microscopy and brightfield to illuminate the cell culture and examine various cell organelles, such as plastids, mitochondria, centrosomes, endoplasmic reticulum, and ribosomes. It is influenced by imaging modality, media, temperature, humidity, pH, osmolarity, and photon dose, which are essential for maintaining cellular health. Live cell imaging also allows monitoring of cell fusion events, determining the mobility of molecules by using fluorescence recovery after photobleaching (FRAP) and measuring various modifications, such as growth or aging of condensate over a period. It provides essential cellular data through the visualization of transient events that are often missed in endpoint assays and revealing optimal time points. It is often utilized to examine the fertilization process, cellular development, cell signaling process, and cell differentiation. Furthermore, as live cell imaging provides accurate information on cell cultures, it is utilized by biologists, pharmacologists, and toxicologists around the world.
At present, the escalating demand for live cell imaging due to its operational efficiency in studying proteins and a wide variety of molecular interactions represents one of the primary factors influencing the market positively. Besides this, there is a rise in the number of innovations made in medical research to develop novel drugs and therapies to treat various life-threatening conditions in individuals. This, coupled with the growing prevalence of various chronic diseases due to the adoption of sedentary lifestyles, is offering a favorable market outlook. In addition, the increasing utilization of high-content screening (HCS) to make drug development processes time and cost-efficient and reduce toxicity is propelling the growth of the market. Apart from this, the rising number of investments made by governing agencies of various countries to improve healthcare infrastructure and develop advanced surgical procedures to provide effective treatment to patients is contributing to the growth of the market. Additionally, the increasing employment of live cell imaging in research laboratories to maintain cell viability is bolstering the market growth. Furthermore, key market players are developing live cell imaging techniques with various enhanced features in camera technology, sensitivity, and pixel density.
IMARC Group provides an analysis of the key trends in each sub-segment of the global live cell imaging market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and technology.
Equipment
Consumable
Software
The report has provided a detailed breakup and analysis of the live cell imaging market based on the product. This includes equipment, consumable, and software. According to the report, equipment represented the largest segment.
Cell Biology
Developmental Biology
Stem Cell and Drug Discovery
Others
A detailed breakup and analysis of the live cell imaging market based on the application has also been provided in the report. This includes cell biology, developmental biology, stem cell and drug discovery, and others. According to the report, cell biology accounted for the largest market share.
Time-Lapse Microscopy
Fluorescence Recovery after Photobleaching (FRAP)
Fluorescence Resonance Energy Transfer (FRET)
High Content Screening (HCS)
Others
A detailed breakup and analysis of the live cell imaging market based on the technology has also been provided in the report. This includes time lapse microscopy, fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high content screening (HCS), and others. According to the report, fluorescence recovery after photobleaching (FRAP) accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for live cell imaging. Some of the factors driving the North America live cell imaging market included rising investments made by governing agencies, increasing occurrence of cancer among the masses, the growing initiatives in drug discovery, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global live cell imaging market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have also been provided. Some of the companies covered include Becton Dickinson and Company (BD), Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Merck KGaA, Nikon Instruments Inc., Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.